JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Technology | 12.2% |
| 3 | Healthcare | 9.44% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
PUT
Signet Jewelers
SIG
$3.6B
| $2.29M | ﹤0.01% |
40,400
| – | – |
|
|
NCI
3102
DELISTED
Navigant Consulting, Inc.
NCI
| $2.28M | ﹤0.01% |
117,259
+28,879
| +33% | +$524K |
|
|
LOXO
3103
CALL
DELISTED
Loxo Oncology, Inc
LOXO
| $2.27M | ﹤0.01% |
+27,000
| New | +$2.25M |
|
|
LOXO
3104
PUT
DELISTED
Loxo Oncology, Inc
LOXO
| $2.27M | ﹤0.01% |
+27,000
| New | +$2.25M |
|
3105
Applied Optoelectronics
AAOI
$11B
| $2.26M | ﹤0.01% |
59,824
-63,601
| -52% | -$2.81M |
|
3106
CALL
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.4B
| $2.26M | ﹤0.01% |
98,700
| – | – |
|
|
NE
3107
PUT
DELISTED
Noble Corporation
NE
| $2.26M | ﹤0.01% |
500,000
| – | – |
|
|
TRTX
3108
TPG RE Finance Trust
TRTX
$616M
| $2.26M | ﹤0.01% |
+118,548
| New | +$2.31M |
|
3109
McGrath RentCorp
MGRC
$2.94B
| $2.26M | ﹤0.01% |
48,052
+26,373
| +122% | +$1.22M |
|
3110
CNA Financial
CNA
$13.8B
| $2.26M | ﹤0.01% |
42,524
+18,420
| +76% | +$970K |
|
3111
PUT
Gogo Inc
GOGO
$377M
| $2.26M | ﹤0.01% |
+200,000
| New | +$2.13M |
|
|
RESI
3112
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $2.25M | ﹤0.01% |
189,886
-145,012
| -43% | -$1.6M |
|
3113
Modine Manufacturing
MOD
$10.8B
| $2.25M | ﹤0.01% |
111,332
+71,971
| +183% | +$1.55M |
|
|
EVHC
3114
CALL
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $2.24M | ﹤0.01% |
+64,700
| New | +$2.26M |
|
3115
iShares US Equity Factor ETF
LRGF
$3.74B
| $2.23M | ﹤0.01% |
70,210
+2,582
| +4% | +$80.6K |
|
|
CRAY
3116
DELISTED
Cray, Inc.
CRAY
| $2.23M | ﹤0.01% |
92,202
+72,424
| +366% | +$1.53M |
|
|
SVM
3117
Silvercorp Metals
SVM
$2.61B
| $2.22M | ﹤0.01% |
848,724
+247,051
| +41% | +$630K |
|
3118
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
| $2.21M | ﹤0.01% |
21,048
+8,652
| +70% | +$912K |
|
3119
Trupanion
TRUP
$1.36B
| $2.21M | ﹤0.01% |
75,383
+69,956
| +1,289% | +$2.06M |
|
3120
First Business Financial Services
FBIZ
$601M
| $2.2M | ﹤0.01% |
99,475
-3,725
| -4% | -$84.2K |
|
3121
Rapid7
RPD
$929M
| $2.2M | ﹤0.01% |
117,858
+34,784
| +42% | +$644K |
|
|
LDL
3122
DELISTED
Lydall, Inc.
LDL
| $2.19M | ﹤0.01% |
43,221
+13,387
| +45% | +$733K |
|
|
KLXI
3123
DELISTED
KLX Inc.
KLXI
| $2.19M | ﹤0.01% |
38,081
+37,220
| +4,323% | +$1.79M |
|
3124
Under Armour
UAA
$2.3B
| $2.19M | ﹤0.01% |
151,547
+45,145
| +42% | +$652K |
|
3125
Unilever
UL
$135B
| $2.18M | ﹤0.01% |
35,020
+7,744
| +28% | +$491K |
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.